Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Alimera Sciences Inc (ALIM)

Alimera Sciences Inc (ALIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alimera Sciences: Q1 Earnings Snapshot

Alimera Sciences: Q1 Earnings Snapshot

ALIM : 5.58 (+0.18%)
Alimera Sciences: Q4 Earnings Snapshot

Alimera Sciences: Q4 Earnings Snapshot

ALIM : 5.58 (+0.18%)
Alimera Sciences: Q3 Earnings Snapshot

Alimera Sciences: Q3 Earnings Snapshot

ALIM : 5.58 (+0.18%)
Alimera Sciences: Q2 Earnings Snapshot

Alimera Sciences: Q2 Earnings Snapshot

ALIM : 5.58 (+0.18%)
Alimera Sciences: Q1 Earnings Snapshot

Alimera Sciences: Q1 Earnings Snapshot

ALIM : 5.58 (+0.18%)
Alimera Sciences: Q4 Earnings Snapshot

Alimera Sciences: Q4 Earnings Snapshot

ALIM : 5.58 (+0.18%)
Alimera Sciences: Q3 Earnings Snapshot

Alimera Sciences: Q3 Earnings Snapshot

ALIM : 5.58 (+0.18%)
Alimera Sciences to Present at the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference

ATLANTA, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be...

ALIM : 5.58 (+0.18%)
Alimera Announces Reimbursement of Uveitis Indication Granted for ILUVIEN® in Portugal

Reimbursement granted with no restrictions to the labelAlimera to begin selling later in Q3 ATLANTA, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences,...

ALIM : 5.58 (+0.18%)
Alimera Sciences Announces Second Quarter 2022 Financial Results

Consolidated Net Product Revenue of $14.6 Million up 36% vs. Second Quarter of 2021U.S. End User Demand up 45% vs. Second Quarter of 2021International...

ALIM : 5.58 (+0.18%)

Barchart Exclusives

3 Top ETFs to Add Small-Cap Stock Exposure
Seeking small-cap equity exposure as Fed rate-cut expectations start to rise? Here are three leading ETFs for small-cap stock investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar